Ning Li

Ning Li is a scientist at Amgen since January 2014, specializing in cardiovascular research within the Metabolic Disorder Department. With extensive experience in isolating and culturing adult and neonatal rodent cardiomyocytes, utilizing Ionoptix technology, and performing echocardiograms and hemodynamic assessments, Ning has a strong background in cardiac modeling. Prior to this role, Ning served as a Post Doctoral Researcher and Senior Research Associate at UC Davis from March 2005 to December 2013, where significant research demonstrated the beneficial effects of soluble epoxide hydrolase inhibitors on cardiac remodeling. Educational qualifications include a PhD in Pharmacology and Toxicology from the University of California, Davis, achieved in 2011, and multiple degrees in related fields from UC Davis, Fudan University, and Shanghai Ocean University.